A breakthrough study published in Science Translational Medicine has illuminated how immune cells trigger progressive kidney damage in lupus patients. Researchers discovered that CD8+ T cells, once infiltrated into kidney tissue, are sustained by specific cytokine signalling pathways that perpetuate inflammation. This mechanism is distinct from the initial activation of these immune cells, offering a critical new understanding of lupus nephritis pathogenesis.
The findings are particularly significant because they point toward selective therapeutic interventions that could block kidney inflammation without broadly suppressing the entire immune system. Current lupus treatments often rely on non-selective immunosuppression, which carries substantial side effects. By targeting the cytokine-mediated pathways that sustain CD8+ T cell activity specifically within kidney tissue, researchers envision more precise treatment strategies that could preserve immune function while protecting vulnerable organs.
Read the full article on GMJ Newsroom.
Was this article helpful?
